Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

INTRODUCTION: One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability. We evaluated Simplified Disease Activity Index (SDAI) remission with abatacept + met...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Tanaka, Yoshiya, Bykerk, Vivian P., Huizinga, Thomas W. J., Citera, Gustavo, Bingham, Clifton O., Banerjee, Subhashis, Soule, Benjamin P., Nys, Marleen, Connolly, Sean E., Lozenski, Karissa L., Zhuo, Joe, Wong, Robert, Huang, Kuan-Hsiang Gary, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140217/
https://www.ncbi.nlm.nih.gov/pubmed/36869251
http://dx.doi.org/10.1007/s40744-022-00519-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140217/
https://www.ncbi.nlm.nih.gov/pubmed/36869251
http://dx.doi.org/10.1007/s40744-022-00519-9

Ejemplares similares